Kadans expands its presence in the United Kingdom by adding its second research hub in the country to its Pan-European science park portfolio.
Kadans acquired Sycamore House from GSK. It is a 9,640 sqm industrial and warehouse building, located directly adjacent to Stevenage Bioscience Catalyst (“SBC”), and the Cell and Gene Therapy Catapult Manufacturing...
The visit marked a Government announcement on plans to develop a new fast-track visa route for the brightest and best scientists to continue to move to the UK after EU Exit.
During his visit, the Prime Minister was shown the work UKAEA is doing to harness the huge potential of nuclear fusion as a low-carbon energy source. This included the new MAST Upgrade fusion...
PM sets out vision to cement UK as a science superpower
The world’s top scientists will be encouraged to move to the UK under a shake-up of immigration rules announced by the Prime Minister.
The Prime Minister, Boris Johnson, said:
Britain has a proud history of innovation, with home-grown inventions spanning from the humble bicycle to the lightbulb.
We were home to...
Isomerase has secured the first pre-let within the Newnham Building at Chesterford Research Park.
The move to Suite 4 of the new building on its completion in mid-2020 will facilitate planned future growth for the successful natural products discovery and development provider.
The Newnham Building is currently being re-configured to create a detached two storey...
Culham Science Centre announces the completion of a new £5.8 million facility, built to support the development of connected and autonomous vehicles (CAV) a sector estimated to be worth £907bn by 2035.
The CAV facility named ‘Pit Lane’ due to its resemblance of a Formula 1 garage, has been developed at Culham Science Centre by RACE, the UK Atomic Energy Authority’s (...